Licht; Danit

Patent Applications and Registrations

Patent applications and USPTO patent grants for Licht; Danit.The latest application filed is for "high concentration dosage forms of pridopidine".

Company Profile

1.5.18

Licht; Danit - Givat Shmuel IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
High concentration dosage forms of pridopidine Grant 11,452,694 - Licht , et al. September 27, 2	2022-09-27
High Concentration Dosage Forms Of Pridopidine App 20200188305 - LICHT; Danit ; et al.	2020-06-18
N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarb- Oxamide, Preparation And Uses Thereof App 20170065576 - Ioffe; Vladimir ; et al.	2017-03-09
Combination Formulation Of Laquinimod And Glatiramer Acetate With Amino Acids App 20170028013 - Linden; Galina ; et al.	2017-02-02
Pridopidine Base Formulations And Their Use App 20170020854 - Licht; Danit ; et al.	2017-01-26
N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarb- Oxamide, Preparation And Uses Thereof App 20160151345 - Ioffe; Vladimir ; et al.	2016-06-02
N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarb- Oxamide, Preparation And Uses Thereof App 20160151346 - Ioffe; Vladimir ; et al.	2016-06-02
R(+)-N-formyl-propargyl-aminoindan Grant 9,346,746 - Safadi , et al. May 24, 2	2016-05-24
R(+)-N-methyl-propargyl-aminoindan Grant 9,339,469 - Safadi , et al. May 17, 2	2016-05-17
N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarb- oxamide, preparation and uses thereof Grant 9,284,276 - Ioffe , et al. March 15, 2	2016-03-15
Laquinimod Formulations Without Alkalizing Agent App 20140018386 - Sarfati; Gadi ; et al.	2014-01-16
N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarb- Oxamide, Preparation And Uses Thereof App 20130217724 - Ioffe; Vladimir ; et al.	2013-08-22
R(+)-n-methyl-propargyl-aminoindan App 20130089610 - Safadi; Muhammad ; et al.	2013-04-11
R(+)-n-formyl-propargyl-aminoindan App 20130089612 - Safadi; Muhammad ; et al.	2013-04-11
Rasagiline Citramide App 20130089611 - Ulanenko; Konstantin ; et al.	2013-04-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.